Tower Research Capital LLC (Trc) Protara Therapeutics, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Protara Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 117 shares of TARA stock, worth $497. This represents 0.0% of its overall portfolio holdings.
Number of Shares
117
Previous 2,783
95.8%
Holding current value
$497
Previous $5,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding TARA
# of Institutions
45Shares Held
11.8MCall Options Held
9KPut Options Held
1.8K-
Ra Capital Management, L.P. Boston, MA1.9MShares$8.08 Million0.05% of portfolio
-
Opaleye Management Inc. Boston, MA1.68MShares$7.14 Million0.56% of portfolio
-
Sio Capital Management, LLC New York, NY1.44MShares$6.11 Million2.82% of portfolio
-
Integral Health Asset Management, LLC1.4MShares$5.95 Million0.66% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.36MShares$5.78 Million0.0% of portfolio
About Protara Therapeutics, Inc.
- Ticker TARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,267,400
- Market Cap $47.9M
- Description
- Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...